Sector portfolio · VC firm · United States
Northern Light Venture Capital's Biotech portfolio
Northern Light Venture Capital has backed 11 Biotech startups in rounds we track, $499M between them, shown by the stage each has reached. The best-funded is Neurophth Therapeutics.
Northern Light Venture Capital's whole portfolioNorthern Light Venture Capital's profile
Funding by segment
- Series A$107M4
- Series C and later$296M4
- Series B$97M3
Where they are based
- China9$375M
- United States2$124M
China
United StatesFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M6
- $50M to $250M4
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- China9
- United States2
Startups by country, 2 countries in all.
Segment by segment
Series A
4 startups · $107M raised
Spiro MedicalSpiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.United States$67M- UTUcello TherapeuticsUcello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.China$21M
Wancheng GeneWancheng Gene is a single-cell gene detection platform that uses the platform to serve the scientific, clinical and industrial markets.China$16M- LLanssonPharmLanssonPharm is a pharmaceutical company.China$3.0M
Series C and later
4 startups · $296M raised
Neurophth TherapeuticsNeurophth Therapeutics is a leading clinical-stage gene therapy company based in Wuhan, China, with additional subsidiaries in ShaChina$97MGenFleet TherapeuticsGenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.China$96M
TenNor TherapeuticsClinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious diseases.United States$57M
WeMedWeMed is an interventional diagnosis and treatment solutions provider.China$46M
Series B
3 startups · $97M raised
Qihan BiotechQihan Biotech is a gene-editing organ transplantation technology developer.China$42M- KKanovaKanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases.China$30M
TenNorTennor is a global investment holding company.China$25M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Northern Light Venture Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Northern Light Venture Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.